<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-114195</identifier>
<setSpec>0034-0618</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Standardization of a cerebral malaria murine model in clinical stages for antimalarial and rescue therapies evaluation</dc:title>
<dc:description xml:lang="en">Cerebral malaria (CM) is included among the more devastating SNC infectious diseases due to its high mortality and severe sequelae in children. Currently, no specific pharmacological treatment for CM or rescue therapy for neurocognitive residual injury are available, and research on this topic has been hampered due to the lack of well-defined experimental models. In the present study we have characterized the CM murine infection phenotypically, evaluating clinical parameters, which allowed establishing a model encompassing four distinct disease stages. This protocol provides the experimental framework to study adjunctive neuroprotective therapies that may prevent and/or eliminate the neurological sequelae in individuals surviving CM  (AU)</dc:description>
<dc:creator>Díez, Amalia</dc:creator>
<dc:creator>Puyet, Antonio</dc:creator>
<dc:creator>Martínez, Gabriela</dc:creator>
<dc:creator>Pérez-Benavente, Susana</dc:creator>
<dc:creator>Linares, María</dc:creator>
<dc:creator>Marín-García, Patricia</dc:creator>
<dc:creator>Bautista, José M</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Entre las enfermedades infecciosas más devastadoras del SNC se incluye la MC, debido a la alta mortalidad y las graves secuelas que ocasiona. Actualmente, no existe tratamiento farmacológico específico, ni de rescate de lesiones neurocognitivas residuales, y su desarrollo está limitado por la inexistencia de modelos experimentales bien definidos. En este trabajo se caracterizó fenotípicamente la infección en un modelo murino de MC evaluando parámetros clínicos que permitieron establecer cuatro estadios de la enfermedad. Este protocolo proporciona el marco experimental adecuado para estudiar terapias coadyuvantes neuroprotectoras que puedan prevenir y/o eliminar las secuelas neurológicas presentes en los individuos que sobreviven (AU)</dc:description>
<dc:source>An Real Acad Farm;79(2): 274-292, abr.-jun. 2013. tab, ilus, graf</dc:source>
<dc:identifier>ibc-114195</dc:identifier>
<dc:title xml:lang="es">Estandarización de un modelo murino de malaria cerebral en fases clínicas para la evaluación de terapias antimaláricas y de rescate</dc:title>
<dc:subject>^d8994</dc:subject>
<dc:subject>^d^s22045</dc:subject>
<dc:subject>^d8462^s22057</dc:subject>
<dc:subject>^d54063^s22073</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d23170^s22021</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:subject>^d965^s22073</dc:subject>
<dc:subject>^d841</dc:subject>
<dc:subject>^d32116^s22073</dc:subject>
<dc:subject>^d35411</dc:subject>
<dc:subject>^d32116^s22044</dc:subject>
<dc:subject>^d965^s22079</dc:subject>
<dc:subject>^d965^s22044</dc:subject>
<dc:subject>^d32116^s22079</dc:subject>
<dc:subject>^d37575</dc:subject>
<dc:type>article</dc:type>
<dc:date>201306</dc:date>
</metadata>
</record>
</ibecs-document>
